ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 38 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,341,000 | -56.5% | 178,109 | -20.6% | 0.36% | -39.4% |
| Q4 2019 | $3,085,000 | +6.9% | 224,359 | -7.7% | 0.59% | -20.1% |
| Q3 2019 | $2,886,000 | -15.1% | 242,950 | 0.0% | 0.74% | +4.3% |
| Q2 2019 | $3,399,000 | -36.6% | 242,950 | -19.0% | 0.70% | -49.7% |
| Q1 2019 | $5,364,000 | +13.7% | 300,000 | 0.0% | 1.40% | -18.2% |
| Q4 2018 | $4,719,000 | – | 300,000 | – | 1.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 6,449,856 | $8,514,000 | 2.83% |
| RA Capital Management | 9,694,789 | $12,797,000 | 0.23% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $9,173,000 | 0.19% |
| HARBOR CAPITAL ADVISORS, INC. | 275,870 | $364,000 | 0.13% |
| Artal Group S.A. | 1,803,858 | $2,381,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 338,756 | $447,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,335,174 | $1,762,000 | 0.05% |
| PVG ASSET MANAGEMENT CORP | 10,000 | $13,200,000 | 0.05% |
| Anson Funds Management LP | 348,266 | $460,000 | 0.04% |
| Eversept Partners, LP | 419,581 | $553,847 | 0.04% |